WearLinq

• ·WearLinq’s last known valuation is $61.0M (Apr 2025).
• ·It has raised $35.0M across 1 recorded rounds; the latest was Early Stage VC ($11.6M) in Apr 2025.
• ·Notable investors include Alumni Ventures, StartX (US), Amino Capital, AIX Ventures, LDV Partners — 21 tracked in total.
• ·1 investment vehicle was formed to buy WearLinq shares in the last 12 months, reporting $347K sold to 36 investors, per SEC Form D filings.
• ·WearLinq has filed 1 Form D with the SEC, most recently May 2025 ($11.6M sold to 26 investors).
• ·Status: Privately Held (backing).

In the last 12 months, 1 investment vehicle were formed to buy WearLinq shares, reporting $347K sold to 36 investors. Most recent filing Oct 2025. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

Developer of a health monitoring and diagnosis device designed to enhance patient care and clinical outcomes. The company's device records a multi-lead electrocardiogram and transmits it in real-time with AI to detect typical irregular heart rhythms, including a normal heart rhythm, bradycardia, and tachycardia, enabling users to discover history and trends, set reminders, and connect directly with physicians.

Sector

Healthcare

HQ

San Francisco, CA, United States

Founded

2020

Employees

19

Website

wearlinq.com/

Ownership

Privately Held (backing)